Biogen stock surges 16% as analysts mostly cheer positive results in Alzheimer’s trial

in #steempress6 years ago


Analysts were nearly all impressed by Biogen and Eisai’s positive results from a mid-stage trial of an Alzheimer’s treatment. But Leerink was a dissenter.











Source: MarketWatch Stories

Details at https://www.marketwatch.com/news/story.asp?guid=%7B019EB4C0-812A-11E8-B5C5-3E2426F3034B%7D&siteid=rss&rss=1



Posted from my blog with SteemPress : https://networkurl.com/story-asp-2239

Sort:  

This user is on the @buildawhale blacklist for one or more of the following reasons:

  • Spam
  • Plagiarism
  • Scam or Fraud